Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2013 061 460.1 |
96 | EP file number | EAKZ | 13 74 0743.3 |
86 | WO file number | WAKZ | PCT/US2013/022772 |
97 | EP publication number | EPN | 2806877 |
87 | WO publication number | WPN | 2013112605 |
54 | Designation/title | TI | NEUROAKTIVE STEROID-FORMULIERUNGEN MIT EINEM KOMPLEX AUS ALLOPREGNANOLON UND SULFOBUTYLETHER BETA-CYCLODEXTRIN |
51 | IPC main class | ICM (ICMV) | A61K 31/57 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 47/69 (2017.01), A61P 25/00 (2006.01), A61P 25/08 (2006.01) |
22 | DE application date | DAT | Jan 23, 2013 |
96 | EP application date | EAT | Jan 23, 2013 |
86 | WO application date | WAT | Jan 23, 2013 |
43 | Date of first publication | OT | Aug 1, 2013 |
| Date of publication of grant | PET | Oct 9, 2019 |
71/73 | Applicant/owner | INH | Sage Therapeutics, Inc., Cambridge, Mass., US |
72 | Inventor | IN | REDDY, Kiran, Cambridge, MA 02142, US |
| Address for service | | Kilburn & Strode LLP, London WC1X 8NL, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261589740 P Jan 23, 2012
|
| Due date | FT FG | Jan 31, 2026 Annual fee for the 14th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002806877 Searchable text:
EP000002806877 Original document:
EP000002806877B1 Searchable text:
EP000002806877B1 Original document:
EP000002806877B2 Searchable text:
EP000002806877B2 Original document:
WO002013112605 Searchable text:
WO002013112605 |
43 | Date of first publication | EVT | Aug 1, 2013 |
| Date of the first transfer into DPMAregister | EREGT | Jan 16, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 9, 2025 (Show all update days)(Hide all update days)- Feb 9, 2025
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 29.01.2025: changed
- Jan 8, 2025
- Due date: changed
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 29.01.2025: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 29.01.2025: new
- Procedures: Procedure relating to PCT application, Publication of PCT application, 01.08.2013: deleted
- Dec 5, 2023; Dec 9, 2022; Dec 8, 2021; Jan 27, 2021; Aug 27, 2020; Jul 23, 2020; Mar 12, 2020; Nov 9, 2019; Oct 31, 2019; Sep 20, 2019; Sep 19, 2019; Aug 14, 2019; Apr 18, 2019; Apr 6, 2017
- Historical data not available for this/these date(s)
- Jan 16, 2015
- Date of the first transfer into DPMAregister
|